Non-Current Liabilities
Bristol-Myers Squibb·Balance Sheet Statement·3 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities | $77.6B | $76.5B | $76.2B | $75B | $77.2B | $78.3B | $71.5B | $66.4B |
| Long-term debt | $48.9B | $48.7B | $47.6B | $46.2B | $44.5B | $44.5B | $42.9B | $42.2B |
| Other non-current liabilities | $5B | $4.7B | $4.5B | $4.5B | $4.9B | $5.5B | $5B | $4.9B |